{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:17:53Z","timestamp":1766157473421},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T00:00:00Z","timestamp":1304467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Therm Anal Calorim"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10973-011-1613-7","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T17:27:37Z","timestamp":1304443657000},"page":"101-108","source":"Crossref","is-referenced-by-count":27,"title":["Crystallinity of Dynasan\u00ae114 and Dynasan\u00ae118 matrices for the production of stable Miglyol\u00ae-loaded nanoparticles"],"prefix":"10.1007","volume":"108","author":[{"given":"Patr\u00edcia","family":"Severino","sequence":"first","affiliation":[]},{"given":"Samantha C.","family":"Pinho","sequence":"additional","affiliation":[]},{"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[]},{"given":"Maria H. A.","family":"Santana","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,5,4]]},"reference":[{"key":"1613_CR1","doi-asserted-by":"crossref","unstructured":"Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Nanomedicine. 2007. doi: 10.1016\/j.nano.2006.11.008 .","DOI":"10.1016\/j.nano.2006.11.008"},{"key":"1613_CR2","doi-asserted-by":"crossref","unstructured":"Aji Alex MR, Chacko AJ, Jose S, Souto EB. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci. 2011. doi: 10.1016\/j.ejps.2010.10.002 .","DOI":"10.1016\/j.ejps.2010.10.002"},{"key":"1613_CR3","doi-asserted-by":"crossref","unstructured":"Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B Biointerfaces. 2010. doi: 10.1016\/j.colsurfb.2010.07.029 .","DOI":"10.1016\/j.colsurfb.2010.07.029"},{"key":"1613_CR4","doi-asserted-by":"crossref","unstructured":"Heney M, Alipour M, Vergidis D, Omri A, Mugabe C, Th\u2019ng J, Suntres Z. Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells. Can J Physiol Pharmacol. 2010. doi: 10.1139\/y10-097 .","DOI":"10.1139\/Y10-097"},{"key":"1613_CR5","doi-asserted-by":"crossref","unstructured":"Wang J, Liu W, Tu Q, Song N, Zhang Y, Nie N. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Biomacromolecules. 2011. doi: 10.1021\/bm101206g .","DOI":"10.1021\/bm101206g"},{"key":"1613_CR6","doi-asserted-by":"crossref","unstructured":"Barata TS, Shaunak S, Teo I, Zloh M, Brocchini S. Structural studies of biologically active glycosylated polyamidoamine (PAMAM) dendrimers. J Mol Model. 2010. doi: 10.1007\/s00894-010-0907-1 .","DOI":"10.1007\/s00894-010-0907-1"},{"key":"1613_CR7","doi-asserted-by":"crossref","unstructured":"Rawat MK, Jain A, Singh S. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats. J Pharm Sci. 2011. doi: 10.1002\/jps.22454 .","DOI":"10.1002\/jps.22454"},{"key":"1613_CR8","doi-asserted-by":"crossref","unstructured":"Souto EB, Muller RH. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol. 2010. doi: 10.1007\/978-3-642-00477-3_4 .","DOI":"10.1007\/978-3-642-00477-3_4"},{"issue":"1","key":"1613_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH Muller","year":"2000","unstructured":"Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161\u201377.","journal-title":"Eur J Pharm Biopharm"},{"key":"1613_CR10","doi-asserted-by":"crossref","unstructured":"De Oliveira GG, Ferraz HG, Severino P, Souto EB. Analysis of phase transition and dehydration processes of nevirapine. J Therm Anal Calorim. 2011. doi: 10.1007\/s10973-011-1424-x .","DOI":"10.1007\/s10973-011-1424-x"},{"key":"1613_CR11","doi-asserted-by":"crossref","unstructured":"Yoshid MI, Oliveira MA, Gomes ECL, Mussel WN, Castro WV, Soares CDV. Thermal characterization of lovastatin in pharmaceutical formulations. J Therm Anal Calorim. 2011. doi: 10.1007\/s10973-011-1510-0 .","DOI":"10.1007\/s10973-011-1510-0"},{"key":"1613_CR12","doi-asserted-by":"crossref","unstructured":"Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 2004. doi: 10.1016\/j.jconrel.2003.11.012 .","DOI":"10.1016\/j.jconrel.2003.11.012"},{"key":"1613_CR13","doi-asserted-by":"crossref","unstructured":"Bondi ML, Craparo EF, Giammona G, Drago F. Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine (Lond). 2009. doi: 10.2217\/nnm.09.67 .","DOI":"10.2217\/nnm.09.67"},{"key":"1613_CR14","doi-asserted-by":"crossref","unstructured":"Souto EB, Muller RH. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul. 2006. doi: 10.1080\/02652040500435295 .","DOI":"10.1080\/02652040500435295"},{"key":"1613_CR15","doi-asserted-by":"crossref","unstructured":"Ali H, Shirode AB, Sylvester PW, Nazzal S. Preparation, characterization, and anticancer effects of simvastatin-tocotrienol lipid nanoparticles. Int J Pharm. 2010. doi: 10.1016\/j.ijpharm.2010.01.018 .","DOI":"10.1016\/j.ijpharm.2010.01.018"},{"key":"1613_CR16","doi-asserted-by":"crossref","unstructured":"Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004. doi: 10.1016\/j.addr.2003.12.002 .","DOI":"10.1016\/j.addr.2003.12.002"},{"key":"1613_CR17","doi-asserted-by":"crossref","unstructured":"Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm. 2008. doi: 10.1080\/03639040802130061 .","DOI":"10.1080\/03639040802130061"},{"key":"1613_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165\u201396.","journal-title":"Adv Drug Deliv Rev"},{"key":"1613_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-5173(00)00623-2","volume":"214","author":"A Lippacher","year":"2001","unstructured":"Lippacher A, Muller RH, Mader K. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. Int J Pharm. 2001;214:9\u201312.","journal-title":"Int J Pharm"},{"key":"1613_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","volume":"242","author":"RH Muller","year":"2002","unstructured":"Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242:121\u20138.","journal-title":"Int J Pharm"},{"key":"1613_CR21","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","volume":"54","author":"RH Muller","year":"2002","unstructured":"Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"1613_CR22","doi-asserted-by":"crossref","unstructured":"Souto EB, Mehnert W, Muller RH. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. J Microencapsul. 2006. doi: 10.1080\/02652040600612439 .","DOI":"10.1080\/02652040600612439"},{"key":"1613_CR23","doi-asserted-by":"crossref","unstructured":"Potta SG, Minemi S, Nukala RK, Peinado C, Lamprou DA, Urquhart A, Douroumis D. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. J Microencapsul. 2011. doi: 10.3109\/02652048.2010.529948 .","DOI":"10.3109\/02652048.2010.529948"},{"key":"1613_CR24","doi-asserted-by":"crossref","unstructured":"Luykx DM, Peters RJ, van Ruth SM, Bouwmeester H. A review of analytical methods for the identification and characterization of nano delivery systems in food. J Agric Food Chem. 2008. doi: 10.1021\/jf8013926 .","DOI":"10.1021\/jf8013926"},{"key":"1613_CR25","doi-asserted-by":"crossref","unstructured":"Rica RA, Jim\u00e9nez ML, Delgado AV. Dynamic mobility of rodlike goethite particles. Langmuir. 2009. doi: 10.1021\/la9013976 .","DOI":"10.1021\/la9013976"},{"key":"1613_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(00)00378-1","volume":"199","author":"V Jenning","year":"2000","unstructured":"Jenning V, Thunemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm. 2000;199:167\u201377.","journal-title":"Int J Pharm"},{"key":"1613_CR27","doi-asserted-by":"crossref","unstructured":"Mezzena M, Scalia S, Young PM, Traini D. Solid lipid budesonide microparticles for controlled release inhalation therapy. AAPS J. 2009. doi: 10.1208\/s12248-009-9148-6 .","DOI":"10.1208\/s12248-009-9148-6"},{"key":"1613_CR28","doi-asserted-by":"crossref","unstructured":"Kim JK, Park JS, Kim CK. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm. 2010. doi: 10.1016\/j.ijpharm.2009.09.008 .","DOI":"10.1016\/j.ijpharm.2009.09.008"},{"key":"1613_CR29","doi-asserted-by":"crossref","unstructured":"Attama AA, Muller-Goymann CC. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Int J Pharm. 2007. doi: 10.1016\/j.ijpharm.2006.10.032 .","DOI":"10.1016\/j.ijpharm.2006.10.032"},{"key":"1613_CR30","doi-asserted-by":"crossref","unstructured":"Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci. 2010. doi: 10.1002\/jps.21944 .","DOI":"10.1002\/jps.21944"}],"container-title":["Journal of Thermal Analysis and Calorimetry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10973-011-1613-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10973-011-1613-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10973-011-1613-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T13:31:03Z","timestamp":1560173463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10973-011-1613-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1007\/s10973-011-1613-7","relation":{},"ISSN":["1388-6150","1572-8943"],"issn-type":[{"value":"1388-6150","type":"print"},{"value":"1572-8943","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,4]]}}}